» Articles » PMID: 25633419

Neural Retinal Disorganization As a Robust Marker of Visual Acuity in Current and Resolved Diabetic Macular Edema

Overview
Journal Diabetes
Specialty Endocrinology
Date 2015 Jan 31
PMID 25633419
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Despite treatment advances, diabetic eye disease remains a leading cause of visual acuity (VA) loss worldwide. No methods to prospectively determine which patients will gain or lose vision exist, limiting individualized risk assessment and management. We investigated whether noninvasive, readily obtainable spectral domain optical coherence tomography parameters were correlated with VA in eyes with current or resolved center-involved diabetic macular edema (DME). Images were evaluated for disorganization of the retinal inner layers (DRIL), cysts, epiretinal membranes, microaneurysms, subretinal fluid, and outer layer disruption/reflectivity. DRIL affecting ≥50% of the 1-mm central retinal zone was associated with worse VA in all eyes, eyes with current edema, and eyes with resolved edema. Furthermore, early 4-month change in DRIL extent predicted VA change from baseline to 1 year. These data suggest that DRIL is a robust predictor of VA in eyes with present or previous DME and more highly correlated with VA than other widely used measures, such as retinal thickness. If further studies confirm DRIL as a predictive biomarker of future VA, physicians would gain a new tool of substantial clinical and investigative importance that could significantly change the approach to ophthalmic counseling and therapeutic management in patients with diabetes.

Citing Articles

Optical Coherence Tomography Biomarkers Predict the Long-Term Restorative Effect of Early Anti-VEGF Treatment on Diabetic Macular Edema.

Okudan S, Acar Duyan S, Erdem A, Bozkurt Oflaz A, Ozturk B Life (Basel). 2025; 15(2).

PMID: 40003678 PMC: 11857452. DOI: 10.3390/life15020269.


Characterization of the Disorganization of the Inner Retinal Layers in Diabetics Using Increased Axial Resolution Optical Coherence Tomography.

Wall K, Arend L, von der Emde L, Sassmannshausen M, Holz F, Ach T Transl Vis Sci Technol. 2025; 14(1):12.

PMID: 39804658 PMC: 11737467. DOI: 10.1167/tvst.14.1.12.


Ultrastructural imaging biomarkers in diabetic macular edema: A major review.

Sen S, Khalid H, Udaya P, Raman R, Rajendram R, ElHousseini Z Indian J Ophthalmol. 2024; 73(Suppl 1):S7-S23.

PMID: 39723865 PMC: 11834929. DOI: 10.4103/IJO.IJO_878_24.


Influence of OCT biomarkers on microperimetry intra- and interdevice repeatability in diabetic macular edema.

Stino H, Birner K, Hinterhuber L, Struppe A, Gumpinger M, Schurer-Waldheim S Sci Rep. 2024; 14(1):23342.

PMID: 39375434 PMC: 11458574. DOI: 10.1038/s41598-024-74230-w.


Intensive Glycemic Management Is Associated With Reduced Retinal Structure Abnormalities on Ocular Coherence Tomography in the DCCT/EDIC Study.

Blodi B, Gardner T, Gao X, Sun J, Lorenzi G, Olmos de Koo L Diabetes Care. 2024; 47(9):1522-1529.

PMID: 38551949 PMC: 11362126. DOI: 10.2337/dc23-2408.


References
1.
Klein R, Klein B, Moss S, Davis M, DeMets D . The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology. 1984; 91(12):1464-74. DOI: 10.1016/s0161-6420(84)34102-1. View

2.
Wolter J . Diabetic retinopathy. Am J Ophthalmol. 1961; 51:1123-41. DOI: 10.1016/0002-9394(61)91802-5. View

3.
BLOODWORTH Jr J . Diabetic retinopathy. Diabetes. 1962; 11:1-22. View

4.
Browning D, Glassman A, Aiello L, Beck R, Brown D, Fong D . Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2006; 114(3):525-36. PMC: 2585542. DOI: 10.1016/j.ophtha.2006.06.052. View

5.
Soliman W, Sander B, Soliman K, Yehya S, Rahamn M, Larsen M . The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema. Acta Ophthalmol. 2007; 86(3):284-91. DOI: 10.1111/j.1600-0420.2007.01048.x. View